Multi4 provides a single‑use, handheld instrument that fits through a standard endoscope channel to deliver local anesthesia, resect tissue, automatically collect samples, and ablate cancer or achieve hemostasis—all in one outpatient visit. By eliminating the need for operating‑room setup, general or spinal anesthesia, catheters, and multiple patient appointments, it reduces procedure time, staffing requirements, and overall treatment costs while maintaining clinical efficacy.
Funding
Funding not disclosed
Founders
Product
Problem
Current bladder cancer diagnosis and treatment rely on invasive transurethral resections that require operating rooms, general or spinal anesthesia, catheterization, and multiple patient visits. The procedures are time‑consuming, labor‑intensive, and contribute to high per‑patient costs and prolonged recovery periods.
Solution
Multi4 offers a single‑use, handheld instrument that fits through the working channel of a standard endoscope, enabling complete bladder cancer treatment in a single outpatient visit. The device integrates four functions—local anesthesia delivery, tissue resection, automatic sample collection, and immediate tissue ablation or hemostasis—eliminating the need for separate tools, catheters, and operating‑room setup. By removing the requirement for fasting, general anesthesia, and hospital admission, the system reduces procedure time, staffing needs, and overall treatment costs while maintaining clinical efficacy. The collected specimens are automatically transferred to a sealed container for pathology, streamlining the diagnostic workflow. This approach transforms bladder cancer care from an inpatient, multi‑step process to a streamlined, patient‑centric outpatient solution.
Target Audience
Primary customers are urologists and outpatient urology clinics that perform cystoscopy and bladder cancer resections, as well as hospitals seeking to shift bladder cancer care to a cost‑effective outpatient model.
Features
- Handheld, ergonomically designed instrument compatible with standard endoscope channels
- Integrated local anesthesia delivery to avoid general or spinal anesthesia
- Simultaneous tissue resection and automatic transport of samples to a sealed pathology container
- Immediate in‑situ tissue ablation or hemostasis to stop bleeding and destroy residual cancer cells
- Single‑use, disposable design ensuring sterility and eliminating instrument reprocessing
- Enables same‑day diagnosis and treatment, reducing patient visits and hospital stay
- Patent‑protected technology scalable to other gastrointestinal and pulmonary cancers